10X Genomics, Inc. (TXG)
62.45
+0.91
(+1.48%)
USD |
NASDAQ |
Aug 31, 16:00
62.24
-0.21
(-0.34%)
After-Hours: 20:00
10X Genomics Cash from Operations (Annual) : 136.05M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 136.05M |
| December 31, 2024 | 6.664M |
| December 31, 2023 | -15.20M |
| December 31, 2022 | -33.61M |
| December 31, 2021 | -21.37M |
| Date | Value |
|---|---|
| December 31, 2020 | -217.90M |
| December 31, 2019 | 34.63M |
| December 31, 2018 | -76.41M |
| December 31, 2017 | -10.70M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Twist Bioscience Corp. | -47.63M |
| Alamar Biosciences, Inc. (California) | -53.61M |
| Personalis, Inc. | -74.95M |
| Adaptive Biotechnologies Corp. | -45.99M |
| Tempus AI, Inc. | -218.09M |